Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.
| Revenue (Most Recent Fiscal Year) | $35.26M |
| Net Income (Most Recent Fiscal Year) | $-69.11M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 9.27 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 7.17 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -204.04% |
| Net Margin (Trailing 12 Months) | -204.01% |
| Return on Equity (Trailing 12 Months) | -186.11% |
| Return on Assets (Trailing 12 Months) | -86.21% |
| Current Ratio (Most Recent Fiscal Quarter) | 5.92 |
| Quick Ratio (Most Recent Fiscal Quarter) | 5.60 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.70 |
| Inventory Turnover (Trailing 12 Months) | 3.11 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.42 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.50 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.66 |
| Diluted Earnings per Share (Trailing 12 Months) | $-2.30 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 54.78M |
| Free Float | 52.21M |
| Market Capitalization | $556.57M |
| Average Volume (Last 20 Days) | 1.12M |
| Beta (Past 60 Months) | 1.04 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.70% |
| Percentage Held By Institutions (Latest 13F Reports) | 12.36% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |